PMID- 32791722
OWN - NLM
STAT- MEDLINE
DCOM- 20200822
LR  - 20240229
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Print)
IS  - 0025-7974 (Linking)
VI  - 99
IP  - 30
DP  - 2020 Jul 24
TI  - Effectiveness comparisons of catgut implantation at acupoint for obese type 2 
      diabetes: A protocol for systematic review and meta analysis.
PG  - e21316
LID - 10.1097/MD.0000000000021316 [doi]
LID - e21316
AB  - BACKGROUND: With the change of people's life style, many more people are 
      suffering from obese type 2 diabetes mellitus (T2DM). Acupoint catgut embedding 
      is one of the acupuncture treatment principles in traditional Chinese medicine, 
      which is widely used in the treatment of obese T2DM. However, there is no 
      systematic review of the therapeutic effect of acupoint catgut embedding on 
      obesity T2DM. Therefore, this article aims at the meta-analysis of acupoint 
      catgut embedding in the treatment of obese T2DM, to clarify its curative effect. 
      METHODS: A structured and systemic literature search was conducted in the 
      following databases up to December 1, 2019: PubMed, Cochrane Central Register of 
      Controlled Trials (CENTRAL), Web of Science, EMBASE, CNKI, Wanfang Database. We 
      will use the Review Manager 5.3 software provided by Cochrane collaborative 
      network for statistical analysis. Then we assessed the quality and risk of the 
      included studies and observed the outcome measures. RESULTS: This meta-analysis 
      will further determine the beneficial efficacy of acupoint catgut embedding on 
      obesity T2DM. CONCLUSION: The purpose of this meta-analysis is to explore the 
      effect of acupoint catgut embedding intervention on obese T2DM patients, and 
      provide more options for clinicians and patients to treat obese T2DM. ETHICS AND 
      DISSEMINATION: This systemic review will evaluate the efficacy and safety of 
      acupoint catgut embedding in the treatment of obesity T2DM. Since all the data 
      included are published, the systematic review does not need ethical approval. 
      REGISTRATION NUMBER: CRD42020160801.
FAU - Piao, Chunli
AU  - Piao C
AD  - Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Shenzhen, 
      Guangdong Province.
FAU - Zhang, Qi
AU  - Zhang Q
AD  - Changchun University of Chinese Medicine, Changchun, Jilin Province.
FAU - Fu, Huiyan
AU  - Fu H
AD  - The Third Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 
      Province, China.
FAU - Wang, Li
AU  - Wang L
AD  - Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Shenzhen, 
      Guangdong Province.
FAU - Tang, Cheng
AU  - Tang C
AD  - Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Shenzhen, 
      Guangdong Province.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - IM
MH  - Female
MH  - Humans
MH  - Male
MH  - *Acupuncture Points/classification
MH  - *Acupuncture Therapy/trends
MH  - *Catgut/adverse effects
MH  - Databases, Factual
MH  - *Diabetes Mellitus, Type 2/epidemiology/therapy
MH  - Life Style
MH  - Medicine, Chinese Traditional
MH  - *Obesity/complications/therapy
MH  - Outcome Assessment, Health Care
MH  - Randomized Controlled Trials as Topic
MH  - Safety
MH  - Treatment Outcome
MH  - Meta-Analysis as Topic
MH  - Systematic Reviews as Topic
PMC - PMC7387063
COIS- The authors report no conflicts of interest.
EDAT- 2020/08/15 06:00
MHDA- 2020/08/22 06:00
PMCR- 2020/07/24
CRDT- 2020/08/15 06:00
PHST- 2020/08/15 06:00 [entrez]
PHST- 2020/08/15 06:00 [pubmed]
PHST- 2020/08/22 06:00 [medline]
PHST- 2020/07/24 00:00 [pmc-release]
AID - 00005792-202007240-00068 [pii]
AID - MD-D-20-04523 [pii]
AID - 10.1097/MD.0000000000021316 [doi]
PST - ppublish
SO  - Medicine (Baltimore). 2020 Jul 24;99(30):e21316. doi: 
      10.1097/MD.0000000000021316.